Dr. Aditya Bardia, MD, MPH, is a breast medical oncologist and physician-scientist whose career focuses on bringing advances in cancer research into everyday patient care. At UCLA, he serves as a professor of medicine and director of Translational Research Integration at the UCLA Health Jonsson Comprehensive Cancer Center.
Bardia has built his career around precision medicine, an approach that uses information about a patient’s cancer to help guide treatment decisions. His research has particularly focused on breast cancer and on developing and evaluating new therapies and technologies.
His work is notable because of its emphasis on translating discoveries from the laboratory into treatments that can reach patients. UCLA describes his approach as “bench-to-bedside” research, with the goal of helping patients benefit from new discoveries as efficiently as possible.
Bardia’s research has contributed to the development and understanding of targeted cancer therapies. His scientific work includes research into breast cancer biology, treatment resistance and therapies designed to target specific characteristics of cancer cells. His published work has included studies involving endocrine therapies and antibody-drug conjugates used in breast cancer treatment.
In 2026, Bardia received an important recognition when he was elected to the American Society for Clinical Investigation (ASCI). Election to the organization is considered one of the significant honors in academic medicine, with only a limited number of physician-scientists selected each year from hundreds of nominations.
The recognition reflects both his research accomplishments and his work as a physician. Rather than focusing exclusively on laboratory discoveries, Bardia has worked to connect research findings with the treatment of real patients.
His recent work also comes at an important time for oncology. Cancer treatment is increasingly moving away from a one-size-fits-all approach toward therapies selected according to tumor biology, genetic characteristics and individual patient factors. Researchers such as Bardia are helping advance this transition.
For MoversAndShakers.io, Dr. Bardia represents the type of physician who combines patient care, research and innovation. His focus on precision medicine demonstrates how modern cancer specialists are helping turn advances in biomedical science into new options for people facing serious disease.
His 2026 election to the ASCI provides another milestone in a career dedicated to improving cancer treatment while helping advance the broader field of translational medicine.
